Samsung Life Science Fund
Incheonsamsungventure.co.kr
Overview
Samsung Life Science Fund is a corporate venture fund that invests in innovative biotech companies with promising technologies in areas including gene therapy, antibody-drug conjugates (ADCs), and AI-based drug discovery.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Latus Bio | May 2026 | Series A | Co-investor |
| C2N Diagnostics | Mar 2025 | Strategic | Co-investor |
| Generate Biomedicines | Dec 2024 | Corporate Funding | Co-investor |
| Latus Bio | May 2024 | Series A | Co-investor |
| BrickBio, Inc. | Mar 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
